Cancer epidemiology studies the frequency, distribution, and determinants of cancer diseases in human populations. Rather than focusing on a single patient in a hospital ward, epidemiologists look at whole communities to track how diseases spread, peak, or decline. This branch of science helps public health planners understand why certain groups get sick more often than others.
At its core, this field provides the evidence base needed to allocate scarce medical resources, plan healthcare infrastructure, and evaluate treatment outcomes across different regions. Without these population-level insights, health ministries would struggle to justify targeted interventions or measure whether public health policies actually reduce disease rates over time.
Cancer remains a leading cause of death worldwide, with low- and middle-income countries bearing a rapidly growing share of the burden. In Nigeria, the most commonly diagnosed malignancies include breast and cervical cancers in women, and prostate cancer in men. Late presentation at health facilities remains a defining feature of the Nigerian cancer profile, often leading to poor survival outcomes.
Factors driving this heavy local burden include limited public awareness, scarce diagnostic equipment, weak referral systems, and out-of-pocket payment models that delay care-seeking. Many patients arrive at tertiary hospitals only when their disease has advanced to stage III or IV, severely limiting the effectiveness of curative treatments.
Measuring the burden of cancer requires specific statistical tools to compare populations accurately.
Cancer development is rarely random; it stems from an interplay of modifiable and non-modifiable factors.
The etiology of cancer involves complex interactions between genes and environmental exposures. While inherited gene mutations like BRCA1 or BRCA2 account for a small percentage of cancers, most malignancies arise from somatic mutations acquired over a lifetime.
Environmental carcinogens, including ionizing radiation, ultraviolet rays from the sun, and occupational chemicals such as asbestos, damage cellular DNA. When combined with lifestyle habits like poor diet and chronic stress, these environmental insults overwhelm the body's natural DNA repair mechanisms, triggering uncontrolled cellular proliferation.
Screening aims to identify pre-cancerous lesions or early-stage malignancies in asymptomatic populations before symptoms appear. Common population-based screening methods include clinical breast examinations, mammography, Pap smears for cervical cancer, and fecal occult blood tests or colonoscopy for colorectal cancer.
Effective screening programs require accessible healthcare facilities, reliable diagnostic laboratories, and established pathways for prompt treatment following a positive test result. In resource-limited settings, visual inspection with acetic acid (VIA) offers a practical, low-cost alternative for cervical cancer screening.
Nurses occupy a front-line position in cancer prevention, community education, and epidemiological data collection. During daily clinical routines, nurses teach patients about tobacco cessation, healthy nutrition, and the importance of participating in screening programs.
Beyond direct patient care, nurses contribute to cancer registries by accurately documenting patient demographics, tumor sites, and staging information. Complete and precise nursing documentation ensures that public health researchers have reliable data to track disease trends, plan interventions, and improve cancer care outcomes nationwide.